DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Granules India Limited
03 1Assia Chemical Industries Ltd - Teva Tech Site
04 1Aurobindo Pharma Limited
05 1Bidachem S.p.a.
06 1Biocon Limited
07 1Boehringer Ingelheim Pharma GmbH and Co. KG
08 1Cipla Ltd.
09 1Glenmark Life Sciences Limited
10 2Honour Lab Limited
11 1MSN Pharmachem Private Limited
12 1MYLAN LABORATORIES LIMITED
13 1Morepen Laboratories Limited
14 1Tianish Laboratories Private Limited
15 1Viyash Life Sciences Private Limited
16 1Zhejiang Huahai Pharmaceutical Co., Ltd.
01 3LINAGLIPTIN
02 12Linagliptin
03 1Linagliptin Premix
04 1linagliptin
01 1China
02 1Germany
03 12India
04 1Israel
05 1Italy
06 1U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-972
Start Marketing Date : 2015-01-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-987
Start Marketing Date : 2024-03-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63415-0521
Start Marketing Date : 2015-08-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51869-0020
Start Marketing Date : 2016-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12714-153
Start Marketing Date : 2011-05-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7701
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62993-0808
Start Marketing Date : 2019-03-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50370-0045
Start Marketing Date : 2014-03-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-854
Start Marketing Date : 2014-12-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64220-184
Start Marketing Date : 2014-09-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Linagliptin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Linagliptin, including repackagers and relabelers. The FDA regulates Linagliptin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Linagliptin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Linagliptin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Linagliptin supplier is an individual or a company that provides Linagliptin active pharmaceutical ingredient (API) or Linagliptin finished formulations upon request. The Linagliptin suppliers may include Linagliptin API manufacturers, exporters, distributors and traders.
click here to find a list of Linagliptin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Linagliptin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Linagliptin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Linagliptin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Linagliptin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Linagliptin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Linagliptin suppliers with NDC on PharmaCompass.
We have 16 companies offering Linagliptin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
